What in the World

Several companies are moving away from the white powder

/by
Vaccines a huge success, but public trust must be earned – key findings from Covid report

Immunisation saved hundreds of thousands of UK lives, but vaccine hesitancy remains an issue.

/by
Vaccines a huge success, but public trust must be earned – key findings from Covid report

Immunisation saved hundreds of thousands of UK lives, but vaccine hesitancy remains an issue.

/by
Covid jabs huge success, but work needed on trust in vaccines – key findings from Covid report

Immunisation saved hundreds of thousands of UK lives, but vaccine hesitancy remains an issue.

/by
Covid jabs huge success, but work needed on trust in vaccines – key findings from Covid report

Immunisation saved hundreds of thousands of UK lives, but vaccine hesitancy remains an issue.

/by
What is the UK Covid inquiry and how does it work?

The fourth report from the inquiry into the pandemic said the vaccine roll-out was an “extraordinary feat”.

/by
What is the UK Covid inquiry and how does it work?

The fourth report from the inquiry into the pandemic said the vaccine roll-out was an “extraordinary feat”.

/by
What is the UK Covid inquiry and how does it work?

The fourth report from the inquiry into the pandemic said the vaccine roll-out was an “extraordinary feat”.

/by
Breakthrough £90,000 Alzheimer’s drugs unlikely to benefit patients, report suggests

A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.

/by
Breakthrough £90,000 Alzheimer’s drugs unlikely to benefit patients, report suggests

A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.

/by